Altrafin AG’s EQT Corp EQT Stock Holding History

Altrafin AG’s Portfolio EQT Stock Details EQT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-27,451	Closed	-$1.02M	–	53
2024 Q2	$1.02M	Sell	27,451 -40,111	-59%	-$1.57M	0.38%	42
2024 Q1	$2.5M	Buy	67,562 +29	+0%	+$1.04K	0.91%	32
2023 Q4	$2.61M	Sell	67,533 -31	-0%	-$1.26K	1.01%	33
2023 Q3	$2.74M	Buy	67,564 +3,496	+5%	+$145K	1.2%	32
2023 Q2	$2.64M	Buy	+64,068	New	+$2.27M	1.18%	28

Other funds holding EQT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

MWM

Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Altrafin AG's EQT Position: Q3 2024 in Review

Altrafin AG sold out of EQT Corp (EQT) in Q3 2024, closing a stake of 27,451 shares — an estimated $1.02M sold.

Altrafin AG first reported a position in EQT in Q2 2023 and held it in 5 quarters. The position peaked at $2.74M in Q3 2023. 737 funds tracked by Wall St. Rank hold EQT as of Q3 2024.

Altrafin AG reported no remaining EQT Corp position as of Q3 2024 after selling out during the quarter.
Altrafin AG sold 27,451 EQT Corp shares in Q3 2024, an estimated $1.02M.
Altrafin AG first reported a position in EQT Corp in Q2 2023 and held it in 5 quarters.
Altrafin AG's EQT Corp position peaked at $2.74M in Q3 2023.
737 funds tracked by Wall St. Rank held EQT Corp as of Q3 2024.

Based on Altrafin AG's 13F filing for Q3 2024, filed 17 Feb 2026.